New perspectives on the development of muscle contractures following central motor lesions

J Pingel1, E M Bartels2, J B Nielsen1

  • 1Department of Exercise, Nutrition and Sports, University of Copenhagen, Denmark.

The Journal of Physiology
|October 26, 2016
PubMed

Insights

Muscle contractures stem from disruptions in tissue homeostasis within the neuromuscular-tendon-connective tissue complex. Understanding the interplay of neural, mechanical, metabolic, and genetic factors is crucial for unraveling their development.

Area of Science:

  • Neurology
  • Physiology
  • Biomedical Engineering

Background:

  • Muscle contractures frequently occur in individuals with central motor lesions.
  • Current understanding of contracture development mechanisms is incomplete.
  • Existing theories involving neural activation, joint positioning, and atrophy are insufficient alone.

Purpose of the Study:

  • To propose a novel framework for understanding muscle contracture development.
  • To emphasize the critical role of tissue homeostasis within the neuromuscular-tendon-connective tissue complex.
  • To advocate for an integrated approach considering multiple physiological factors.

Main Methods:

  • Conceptual review and synthesis of existing literature.
  • Proposal of a new theoretical model for contracture etiology.
  • Identification of key interacting factors: neural, mechanical, metabolic, genetic, and epigenetic.

Main Results:

  • Tissue homeostasis alterations in the neuromuscular-tendon-connective tissue complex are central to contracture development.
  • No single factor adequately explains contracture formation.
  • An integrated physiological perspective is necessary.

Conclusions:

  • Muscle contractures result from complex interactions within the neuromuscular system.
  • Future research should focus on the interplay of neural, mechanical, metabolic, and genetic factors.
  • This integrated approach may lead to new therapeutic strategies for muscle contractures.

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.3K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.8K
Motor Unit Stimulation01:20

Motor Unit Stimulation

When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
4.3K